Momenta Pharmaceuticals, Inc. (MNTA)

[pollyvonwog]

Maybe I'm missing something but I'm a little confused on how it "grew"? Anyone care to chime in?

This is from Q2

Sandoz continued to strengthen its leading position in differentiated generics, with global sales of Biopharmaceuticals (which include biosimilars, biopharmaceutical contract manufacturing and Glatopa) up 57% (cc) to USD 222 million in the second quarter, driven in part by shipping of initial trade inventories of Glatopa in June.